Status:
COMPLETED
The Efficacy and Safety of Repeat-dose Potenfill for Temporary Penile Enhancement
Lead Sponsor:
Medy-Tox
Conditions:
Penile Girth Enhancement
Penile Enhancement
Eligibility:
MALE
19-65 years
Phase:
NA
Brief Summary
This clinical study is for small-penis syndrome males who have previously been treated with hyaluronic acid filler for the purpose of increasing their penis. This study will determine the long-term e...
Eligibility Criteria
Inclusion
- Male subjects aged above 19 and below 65. (20≤male≥65)
- Subjects will sign an informed consent form
Exclusion
- Prior treatment for penile enhancement (e.g. fat, dermal graft).
- Allergic to hyalluronic acid.
Key Trial Info
Start Date :
December 17 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03840070
Start Date
December 17 2018
End Date
December 30 2019
Last Update
July 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Korea university guro hospital
Seoul, South Korea